Table 2.
Survival characteristics of patients related to their tumoral GPC6 and TMEM132D mRNA levels.
| All | GPC6 mRNA levels | TMEM132D mRNA levels | GPC6/TMEM132D mRNA levels | ||||
|---|---|---|---|---|---|---|---|
| Low | High | Low | High | Both low | High GPC6 and/or TMEM132D | ||
| N (%) | 35 | 28 (80) | 7 (20) | 26 (74.3) | 9 (25.7) | 22 (62.9) | 13 (37.1) |
| Survival | |||||||
| 5-year survival (%) | 91.34 ± 4.78 | 88.73 ± 6.13 | 100 | 88.29 ± 6.36 | 100 | 85.45 ± 7.78 | 100 |
| 10-year survival (%) | 84.69 ± 6.34 | 80.06 ± 8.04 | 100 | 78.73 ± 8.55 | 100 | 73.62 ± 10.27 | 100 |
| Overall survival (months) | |||||||
| Mean ± SE | 189 ± 12 | 179 ± 15 | Undefineda | 152 ± 13 | Undefineda | 144 ± 15 | Undefineda |
| 95% C.I. | 164–213 | 149–209 | — | 126–177 | — | 114–174 | — |
| Death cases (%) | 6 (17.14%) | 6 (21.4) | 0 (0) | 6 (23.1) | 0 (0) | 6 (27.3) | 0 (0) |
|
| |||||||
| p value (log-rank test) | 0.214 | 0.099 | 0.032 | ||||
aAll subjects alive.